Literature DB >> 22231868

Genotype and phenotype study of 34 Spanish patients diagnosed with oculopharyngeal muscular dystrophy.

Mireia Tondo1, Josep Gámez, Eduardo Gutiérrez-Rivas, Ramón Medel-Jiménez, Loreto Martorell.   

Abstract

Oculopharyngeal muscular dystrophy is an autosomal dominant adult-onset disease with several clinical features. The genetic cause is an expanded (GCN)n mutation coding for polyalanine. Severity and the age of onset are variable and may depend on the size of the unstable triplet. Our objectives were to correlate the genotypic and phenotypic features in 34 affected patients, and to complete the molecular analysis for a control Spanish population in order to confirm the (GCN)n polymorphism frequency observed in other populations. We found a correlation between impaired CPK levels and sex. No statistical differences were found when comparing the length in triplet expansion and other variables. The (GCN)n polymorphism's frequency observed in other countries could not be proven in ours. Moreover, no correlation was observed amongst the size of the mutation, the age of onset, and the phenotype. This fact suggests that other conditions apart from the already known genotype could influence the age of onset and the severity of the symptoms.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22231868     DOI: 10.1007/s00415-011-6374-5

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  14 in total

1.  Variability of the recessive oculopharyngeal muscular dystrophy phenotype.

Authors:  Alexander Semmler; Wolfram Kress; Stefan Vielhaber; Rolf Schröder; Cornelia Kornblum
Journal:  Muscle Nerve       Date:  2007-05       Impact factor: 3.217

2.  GCG repeats and phenotype in oculopharyngeal muscular dystrophy.

Authors:  T Müller; R Schröder; S Zierz
Journal:  Muscle Nerve       Date:  2001-01       Impact factor: 3.217

3.  Short GCG expansions in the PABP2 gene cause oculopharyngeal muscular dystrophy.

Authors:  B Brais; J P Bouchard; Y G Xie; D L Rochefort; N Chrétien; F M Tomé; R G Lafrenière; J M Rommens; E Uyama; O Nohira; S Blumen; A D Korczyn; P Heutink; J Mathieu; A Duranceau; F Codère; M Fardeau; G A Rouleau; A D Korcyn
Journal:  Nat Genet       Date:  1998-02       Impact factor: 38.330

4.  Unusual triplet expansion associated with neurogenic changes in a family with oculopharyngeal muscular dystrophy.

Authors:  R Schober; W Kress; F Grahmann; S Kellermann; P Baum; S Günzel; A Wagner
Journal:  Neuropathology       Date:  2001-03       Impact factor: 1.906

5.  Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9.

Authors:  C L Liquori; K Ricker; M L Moseley; J F Jacobsen; W Kress; S L Naylor; J W Day; L P Ranum
Journal:  Science       Date:  2001-08-03       Impact factor: 47.728

6.  Oculopharyngeal muscular dystrophy in France.

Authors:  M Fardeau; F M Tomé
Journal:  Neuromuscul Disord       Date:  1997-10       Impact factor: 4.296

7.  Oculopharyngeal muscular dystrophy in Uruguay.

Authors:  M Medici; C Pizzarossa; D Skuk; D Yorio; G Emmanuelli; R Mesa
Journal:  Neuromuscul Disord       Date:  1997-10       Impact factor: 4.296

8.  Genetic heterogeneity in 30 German patients with oculopharyngeal muscular dystrophy.

Authors:  T Müller; M Deschauer; F Kolbe-Fehr; St Zierz
Journal:  J Neurol       Date:  2006-04-20       Impact factor: 4.849

Review 9.  Oculopharyngeal muscular dystrophy: a polyalanine myopathy.

Authors:  Bernard Brais
Journal:  Curr Neurol Neurosci Rep       Date:  2009-01       Impact factor: 5.081

10.  Somatic heterogeneity of the CTG repeat in myotonic dystrophy is age and size dependent.

Authors:  L J Wong; T Ashizawa; D G Monckton; C T Caskey; C S Richards
Journal:  Am J Hum Genet       Date:  1995-01       Impact factor: 11.025

View more
  8 in total

1.  Hip flexion weakness is associated with impaired mobility in oculopharyngeal muscular dystrophy: a retrospective study with implications for trial design.

Authors:  Sarah Youssof; Ronald Schrader; David Bear; Leslie Morrison
Journal:  Neuromuscul Disord       Date:  2014-11-20       Impact factor: 4.296

2.  Assessment of PABPN1 nuclear inclusions on a large cohort of patients and in a human xenograft model of oculopharyngeal muscular dystrophy.

Authors:  Fanny Roth; Jamila Dhiab; Alexis Boulinguiez; Hadidja-Rose Mouigni; Saskia Lassche; Elisa Negroni; Laura Muraine; Alix Marhic; Alison Oliver; Jeanne Lainé; Andrée Rouche; Erin K O'Ferrall; Baziel van Engelen; Coen Ottenheijm; Hagar Greif; Sergiu Blumen; Jean Lacau St Guily; Sophie Perie; Gillian Butler-Browne; Vincent Mouly; Capucine Trollet
Journal:  Acta Neuropathol       Date:  2022-10-05       Impact factor: 15.887

3.  Screening for the presence of FMR1 premutation alleles in a Spanish population with fibromyalgia.

Authors:  Loreto Martorell; Mireia Tondo; Ferrán Garcia-Fructuoso; Montserrat Naudo; Cayetano Alegre; Josep Gamez; Jordi Genovés; Pilar Poo
Journal:  Clin Rheumatol       Date:  2012-08-18       Impact factor: 2.980

4.  Oculopharyngeal muscular dystrophy: phenotypic and genotypic studies in a Chinese population.

Authors:  Jingli Shan; Bin Chen; Pengfei Lin; Duoling Li; Yuebei Luo; Kunqian Ji; Jinfan Zheng; Yun Yuan; Chuanzhu Yan
Journal:  Neuromolecular Med       Date:  2014-10-05       Impact factor: 3.843

5.  Correlation between PABPN1 genotype and disease severity in oculopharyngeal muscular dystrophy.

Authors:  Pascale Richard; Capucine Trollet; Tanya Stojkovic; Alix de Becdelievre; Sophie Perie; Jean Pouget; Bruno Eymard
Journal:  Neurology       Date:  2016-12-23       Impact factor: 9.910

6.  PABPN1 (GCN)11 as a Dominant Allele in Oculopharyngeal Muscular Dystrophy -Consequences in Clinical Diagnosis and Genetic Counselling.

Authors:  Pascale Richard; Capucine Trollet; Teresa Gidaro; Laurence Demay; Guy Brochier; Edoardo Malfatti; Fernando Ms Tom; Michel Fardeau; Pascal Lafor; Norma Romero; Marie-Laure Martin-N; Guilhem Sol; Xavier Ferrer-Monasterio; Jean Lacau Saint-Guily; Bruno Eymard
Journal:  J Neuromuscul Dis       Date:  2015-06-04

7.  Diagnostics of short tandem repeat expansion variants using massively parallel sequencing and componential tools.

Authors:  Rick H de Leeuw; Dominique Garnier; Rosemarie M J M Kroon; Corinne G C Horlings; Emile de Meijer; Henk Buermans; Baziel G M van Engelen; Peter de Knijff; Vered Raz
Journal:  Eur J Hum Genet       Date:  2018-11-19       Impact factor: 4.246

Review 8.  Recent Progress in Oculopharyngeal Muscular Dystrophy.

Authors:  Satoshi Yamashita
Journal:  J Clin Med       Date:  2021-03-29       Impact factor: 4.241

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.